David Trenk | executive |
Christopher Simon | executive |
James D'Arecca | executive |
Anthony Petrone | analyst |
Lawrence Solow | analyst |
David Turkaly | analyst |
Michael Matson | analyst |
Andrew Ranieri | analyst |
Michael Petusky | analyst |
Good day, and thank you for standing by. Welcome to the Fourth Quarter 2023 Haemonetics Corporation's Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker today, David Trenk, Investor Relations. Please go ahead.